TXG vs. CYBR
TXG (10x Genomics, Inc.) and CYBR (CyberArk Software Ltd.) are both stocks. TXG operates in Health Information Services (Healthcare), while CYBR operates in Software - Infrastructure (Technology). At a 0.37 correlation, their price movements are largely independent.
Performance
TXG vs. CYBR - Performance Comparison
Loading charts...
Returns By Period
TXG
- 1D
- -5.22%
- 1M
- 39.10%
- YTD
- 101.96%
- 6M
- 94.45%
- 1Y
- 204.72%
- 3Y*
- -15.51%
- 5Y*
- -30.38%
- 10Y*
- —
CYBR
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TXG vs. CYBR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
TXG 10x Genomics, Inc. | 101.96% | 13.58% | -74.34% | 53.57% | -75.54% | 5.20% | 85.70% | 41.20% |
CYBR CyberArk Software Ltd. | -8.34% | 33.89% | 52.09% | 68.95% | -25.18% | 7.23% | 38.61% | 17.14% |
Correlation
The correlation between TXG and CYBR is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.37 |
Correlation (All Time) Calculated using the full available price history since Sep 12, 2019 | 0.37 |
Over the past year, the correlation between TXG and CYBR has dropped to 0.12 - well below their long-term average of 0.37, suggesting their price drivers have been diverging.
Fundamentals
TXG:
$4.23B
CYBR:
$20.69B
TXG:
-$0.18
CYBR:
-$2.92
TXG:
6.52
CYBR:
15.13
TXG:
5.19
CYBR:
8.61
TXG:
$638.78M
CYBR:
$1.36B
TXG:
$444.61M
CYBR:
$1.01B
TXG:
-$5.89M
CYBR:
$59.13M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TXG vs. CYBR — Risk / Return Rank
TXG
CYBR
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
TXG vs. CYBR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for 10x Genomics, Inc. (TXG) and CyberArk Software Ltd. (CYBR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TXG | CYBR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.39 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 7.35 | — | — |
| Martin ratioReturn relative to average drawdown | 16.73 | — | — |
Loading charts...
Drawdowns
TXG vs. CYBR - Drawdown Comparison
Loading charts...
Drawdown Indicators
| TXG | CYBR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.47% | — | — |
Max Drawdown (1Y)Largest decline over 1 year | -28.03% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -88.66% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -96.45% | — | — |
Current DrawdownCurrent decline from peak | -83.72% | — | — |
Average DrawdownAverage peak-to-trough decline | -59.78% | — | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.29% | — | — |
Volatility
TXG vs. CYBR - Volatility Comparison
Loading charts...
Volatility by Period
| TXG | CYBR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.47% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 48.22% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 69.06% | — | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 68.74% | — | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 66.90% | — | — |
Dividends
TXG vs. CYBR - Dividend Comparison
Neither TXG nor CYBR has paid dividends to shareholders.
Financials
TXG vs. CYBR - Financials Comparison
This section allows you to compare key financial metrics between 10x Genomics, Inc. and CyberArk Software Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TXG vs. CYBR - Profitability Comparison
TXG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, 10x Genomics, Inc. reported a gross profit of 106.18M and revenue of 150.84M. Therefore, the gross margin over that period was 70.4%.
CYBR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CyberArk Software Ltd. reported a gross profit of 267.25M and revenue of 372.65M. Therefore, the gross margin over that period was 71.7%.
TXG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, 10x Genomics, Inc. reported an operating income of -17.05M and revenue of 150.84M, resulting in an operating margin of -11.3%.
CYBR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CyberArk Software Ltd. reported an operating income of 1.75M and revenue of 372.65M, resulting in an operating margin of 0.5%.
TXG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, 10x Genomics, Inc. reported a net income of -13.47M and revenue of 150.84M, resulting in a net margin of -8.9%.
CYBR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CyberArk Software Ltd. reported a net income of -17.11M and revenue of 372.65M, resulting in a net margin of -4.6%.
Frequently Asked Questions
TXG and CYBR have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for TXG and CYBR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer